however, if rap1-gtp levels remain low, structural constraints (blue arrows) force the equilibrium towards the inactive form.
Mn 2+ treatment (grey arrow) does not activate Rap1, although endogenous levels of active Rap1 still control Mn 2+ -induced integrin activation.